Tag: ABBV

Top Yielding Dividend Aristocrats

by Fred Fuld III

Dividend Aristocrats are a group of 65 S&P 500 stocks that have increased their dividends annually for at least 25 consecutive years. They are considered to be some of the most reliable dividend-paying stocks on the market.

The Dividend Aristocrats index is maintained by S&P Dow Jones Indices. To qualify for the index, a stock must meet the following criteria:

  • It must be a member of the S&P 500 index.
  • It must have increased its dividend for at least 25 consecutive years.
  • It must have a market capitalization of at least $3 billion.

The Dividend Aristocrats index is a popular investment among investors who are looking for income and growth. The stocks in the index have a long track record of dividend growth, and they are typically well-established companies with strong financials.

Here are some of the top Dividend Aristocrats in 2023, ranked by their forward dividend yield:

  • Realty Income (O): 5.0%
  • IBM (IBM): 5.0%
  • AbbVie (ABBV): 4.4%
  • Coca-Cola (KO): 3.0%
  • Johnson & Johnson (JNJ): 3.0%
  • Procter & Gamble (PG): 2.5%
  • Pepsico (PEP): 2.7%

These stocks are all paying a high dividend yield, and they have a long track record of dividend growth. They are a good option for investors who are looking for income and growth.

Here are some of the benefits of investing in Dividend Aristocrats:

  • Income: Dividend Aristocrats are a good source of income for investors. They typically pay a high dividend yield, and they have a long track record of dividend growth.
  • Growth: Dividend Aristocrats can also provide growth potential for investors. Many of the companies in the index are well-established and have strong financials. This means that they are likely to continue to grow their businesses and their dividends over time.
  • Safety: Dividend Aristocrats are considered to be relatively safe investments. They are typically large, well-established companies with a long track record of profitability. This means that they are less likely to go bankrupt or cut their dividends than smaller, more volatile companies.

If you are looking for an investment that can provide you with income and growth, then Dividend Aristocrats may be a good option for you. They are a relatively safe investment that has the potential to provide you with a steady stream of income over the long term.

Disclosure: Author owns PEP.

Warren Buffett’s Portfolio Changes in Berkshire Hathaway

by Fred Fuld III

Warren Buffett has had a very long and successful career as a portfolio manager for Berkshire Hathaway. Many investors like to follow in his footsteps, at least in terms of buying the game long term investments that he is buying.

His Berkshire Hathaway stock has had an average annual return of around 20% since 1965. Not too shabby since the S&P 500 has only had a little over 10% average annual return over the same time frame.

So what has Warren Buffett been doing lately?

Warren Buffett Purchases

First, his buys. Buffett has purchased over 136 million shares of Occidental Petroleum (OXY) since the beginning of the year.

He also bought 104 million shares of HP Inc. (HPQ), and 55 million shares of Citigroup (C).

In addition, Buffett has added the following stocks to the Berkshire portfolio:

  • Celanese (CE)
  • Paramount Global (PARA)
  • McKesson (MCK)
  • Markel (MKL)
  • Ally Financial (ALLY)

Warren Buffett Sales

Buffett has also been liquidating some stocks in the Berkshire portfolio. These include:

  • Wells Fargo (WFC)
  • Abbvie (ABBV)
  • Bristol-Myers Squibb (BMY)

To see the full portfolio of Warren Buffett’s Berkshire Hathaway, click HERE.

Of course, if you really want to match the return of Berkshire Hathaway, you might as well buy the A shares (BRK-A) or the B shares (BRK-B) of the company.

Remember what Warren Buffett said:

“Don’t buy a stock unless you think it’s undervalued.”

 

Disclosure: Author didn’t own any of the above at the time the article was written.

What Warren Buffett is Dumping and Buying

by Fred Fuld III

You know, if you are thinking of investing in Apple (AAPL) stock, you just might want to consider buying shares of Warren Buffett’s Berkshire Hathaway (BRK-A) (BRK-B) stock, as 40% of the Berkshire portfolio is made up of Apple.

This way, if Apple does well, you participate through Berkshire, and if it doesn’t, at least you have diversification though Berkshire’s ownership of over 45 other stocks.

So let’s look at the rest of Buffett’s portfolio. In the first quarter of the year, he sold out of two companies, Suncor Energy (SU) and Synchrony Financial (SYF).

Warren Buffett has been reducing positions in a couple bank stocks, US Bancorp (USB) and Wells Fargo (WFC). He has also been lightening up on General Motors (GM), Chevron (CVX), Abbvie (ABBV), Bristol-Myers Squibb (BMY), Merck (MRK), Stoneco (STNE), Axalta Coating (AXTA), Sirius XM Radio (SIRI), and Liberty Global (LBTYA).

He hasn’t been buying much, but he has been adding to his positions in Verizon (VZ), buying over 12 million additional shares. He also added 17.5 million shares to his Kroger (KR) position, and bought more Restoration Hardware (RH) and Marsh & McLellan (MMC).

There is one brand new stock in the Berkshire Hathaway portfolio., the insurance company Aon (AON). The stock has a trailing price to earnings ratio of 27.5 and a forward P/E of 22.5. It pays a yield of 0.81%.

To see the list of all the Warren Buffett holdings, click HERE.

Maybe some of these stocks will make you as successful as Warren Buffett.

 

Disclosure: Author owns AAPL.

High Yield Cannabis Stocks

by Fred Fuld III

During the last twelve months, many of the cannabis stocks, such as (TLRY) and Canopy Growth (CGC), have been hit hard with some stocks, such a Tilray (TLRY) dropping 76% and Canopy Growth (CGC) down 54%. Some investors and traders think that the marijuana stocks may have hit bottom and there may be some buying opportunities.

However, if  you are a relatively conservative investor, you probably want to receive a dividend in return for the risk you are taking. Luckily, there are some cannabis stocks that provide investors with a decent dividend yield.

One example is Scotts Miracle-Gro Company (SMG), which has a couple divisions in the marijuana industry. Its Hawthorne Gardening Company division purchased General Hydroponics which manufactures and sells products for marijuana growers. Scotts has also invested in the hydroponics company AeroGrow International (AERO) which sells products to the small scale grower. Scotts’ current yield is 1.92%. Last August, the company raised its dividend to 58 cents per share, an incense of 5.5% over the previous quarter. The dividend has increased on an annual basis since 2015. The stock has a trailing price to earnings ratio of 15 and a forward PE of 22.

AbbVie Inc. (ABBV) is a seller of Marinol, also known as Dronabinol, a form of tetrahydrocannabinol, one of the main psychoactive ingredients of marijuana. The company has been paying quarterly dividends and has increased the annual dividend every year since 2013. AbbVie’s annual forward dividend yield is 5.77%. The company just raised its dividend to $1.07 per share per quarter, a 9.3% increase. The stock trades at 37 times trailing earnings and 8.5 times forward earnings.

Innovative Industrial Properties Inc. (IIPR), which trades on the New York Stock Exchange,  owns, manages, and leases real estate to state licensed cannabis growing businesses. The company has increased dividend every quarter for the last four quarters, the latest dividend increasing my 28%. The company pays a dividend yield of 4.25%. The stock trades at 62 times trailing earnings and 20 times forward earnings.

Horizons Marijuana Life Sciences Index ETF (HMLSF) is an exchange traded fund that invests in many companies involved in the marijuana industry. It has a yield of 12%, based on its latest quarterly payment of $0.202 per share. The reason why the dividend income is so high is because most of the income comes from fees and interest from securities lending. This ETF’s largest holdings are:

  1. CANOPY GROWTH CORP.   13.42%
  2. CRONOS GROUP INC.   11.01%
  3. GW PHARMACEUTICALS PLC.   10.12%
  4. TILRAY INC.   9.05%
  5. APHRIA INC.   8.98%
  6. AURORA CANNABIS INC.   6.51%
  7. SCOTTS MIRACLE-GRO CO.   6.49%
  8. CHARLOTTES WEB HOLDINGS INC.   6.21%
  9. INNOVATIVE INDUSTRIAL PROPERT.   3.11%
  10. ORGANIGRAM HOLDINGS INC.   2.61%

Altria (MO) is primarily in the tobacco business, as it manufactures and markets cigarettes and smokeless tobacco. The company invested over a billion dollars in Cronos Group (CRON), the Canadian marijuana company. The stock pays a generous yield of 7.0%.

Molson Coors (TAP) is the seventh largest beer maker in the world. The company is in partnership with HEXO (HEXO) to produce cannabis-infused beverages in Canada. Molson Coors yields 4.05%.

Constellation Brands (STZ), which produces and markets beer, wine, and liquor, has a major ownership of shares in the Ontario, Canada based cannabis company Canopy Growth (CGC). Constellation has a dividend yield of 1.56%.

To be blunt about it, here’s the straight dope. Maybe some of these stocks will get high, and give you a smoking portfolio from this budding industry. You may even hit the jack pot. Just make sure you weed out the bad stocks, because if you don’t, your portfolio will take a hit and go up in smoke.

Don’t forget to read:

Exclusive Interview with Chet Billingsley CEO of Mentor Capital on the Marijuana Industry

Is Apple Getting into the Marijuana Industry?

Disclosure: Author owns CGC and IIPR.

Highest Yielding Marijuana Cannabis Pot Stocks

by Fred Fuld III

You may have seen some of the major gains in some of the marijuana stocks and wanted to jump on the bandwagon. As an example, Cronos (CRON) has increased by 13% so far this year and Aurora (ACB) rose 26% even after experiencing a big drop during the last six months.

Maybe you are a relatively conservative investor and you want to receive a dividend in return for the risk you are taking. Fortunately, there are several cannabis stocks that provide investors with a yield.

Scotts Miracle-Gro Company (SMG) has a couple divisions in the marijuana industry. Its Hawthorne Gardening Co. subsidiary purchased General Hydroponics which makes and markets products for the pot growers. The company has also invested in the hydroponics company AeroGrow International (AERO) which markets to the small scale grower. Scotts’ current yield is 2.17%, with the latest dividend of 58 cents paid September 10 (today), an incense of 5.5% over the previous quarter. The dividend has increased on an annual basis since 2015.

AbbVie Inc. (ABBV), the marketer of Marinol also known as Dronabinol, a form of tetrahydrocannabinol, one of the main psychoactive ingredients of marijuana. The company has been paying quarterly dividends and has increased the annual dividend every year since 2013. AbbVie’s annual forward dividend yield is 6.28%. The company’s most recent dividend is $1.07 per share, which will be paid to investors on November 15, 2019 to shareholders of record on October 11.

Innovative Industrial Properties Inc. (IIPR), which trades on the New York Stock Exchange,  owns, manages, and leases properties to state licensed cannabis growing facilities. Annual dividends since 2017 were 55 cents, $1.20, and $2.40. The dividends are paid quarterly, currently 60 cents per share, up from 45 cents for the previous quarter, an increase of 33%. The company pays a dividend yield of 2.79%.

Altria (MO) is the tobacco company that manufactures and markets cigarettes and smokeless tobacco. The company invested over a billion dollars in Cronos Group (CRON), the Canadian marijuana company. The stock has a forward yield of 7.9%.

Molson Coors (TAP) is the seventh largest brewer in the world. The company is in partnership with HEXO (HEXO) to produce cannabis-infused beverages in Canada. Molson Coors yields 4.03%.

Horizons Marijuana Life Sciences Index ETF (HMLSF) is an exchange traded fund that invests in many companies involved in the marijuana industry. It has a yield of 7.54%.

Constellation Brands (STZ), the beer, wine, and liquor producer, has a significant ownership in the Ontario, Canada based cannabis company Canopy Growth (CGC). Constellation has a dividend yield of 1.44%.

Let’s hope some of these stocks get high, and provide you with a smoking portfolio.

Don’t forget to read:

Exclusive Interview with Chet Billingsley CEO of Mentor Capital on the Marijuana Industry

Is Apple Getting into the Marijuana Industry?

Disclosure: Author owns CGC and a long option position in ACB.

Marijuana Legalization & Top Pot Stocks

by Nkem Iregbulem

Although marijuana can be used recreationally, medical marijuana has become increasingly popular over recent years as a growing amount of research supports its potential health benefits. Small studies show that medical marijuana may help in treating pain, nausea, loss of appetite, irritable bowel syndrome, Parkinson’s disease, epilepsy, and multiple sclerosis. D.C. and 31 states, including California, Nevada, Maine, Massachusetts, and Washington, have legalized medical marijuana. Meanwhile, the recreational use of marijuana is legal in 9 states, including California, Alaska, Oregon, and Colorado.

On June 21, the Canadian Senate passed the Cannabis Act, which regulates the production, distribution, and sale of marijuana in Canada. These plans have set off an investment boom or “green rush” in Canada as sales of certain forms of cannabis such as fresh or dried cannabis, cannabis oil, and plants and seeds for cultivation will now become legal. Canada will be the second country, after Uruguay, to legalize the sale of recreational marijuana.

This growing interest in marijuana may compel you to invest in pot stocks. If you are looking to gain exposure to the marijuana industry, you have a number of investment opportunities: AbbVie (ABBV), Aurora Cannabis (ACBFF), Canopy Growth (CGC), Constellation Brands (STZ), Cronos Group (CRON), GW Pharmaceuticals (GWPH), Scotts Miracle-Gro (SMG), and Tilray (TLRY). The ABBV, CGC, STZ, and SMG stocks are traded on the New York Stock Exchange, and ACBFF is traded in over-the-counter markets. Meanwhile, the CRON, GWPH, and TLRY stocks can all be found on the NASDAQ.

Your first option is AbbVie, a drug company that discovers, develops, manufactures, and sells pharmaceutical products worldwide. One of its products, Marinol, is a synthetic cannabis-based drug designed to not only helps chemotherapy patients with symptoms like nausea and vomiting but also help AIDS patients with their loss of appetite. The company was founded in 2012 and is headquartered in Illinois. AbbVie has a market cap of $144 billion and pays a dividend yield of 2.3%. The company’s stock trades at 23.67 times trailing earnings and at 10.74 times forward earnings. The stock has a price-to-book ratio of 42.01, and a price-to-sales ratio of 4.93, which would put it in the overpriced range. The company enjoys a three year revenue growth rate of 12.23% and a five year revenue growth rate of 8.95%. Its revenue has been increasing each fiscal year since 2013.

Aurora Cannabis, founded in 2006, is another option to consider. The company is based in Vancouver, Canada and is involved in the production and distribution of medical cannabis in Canada and internationally. The company’s product portfolio includes dried cannabis and cannabis oil. Aurora Cannabis has a market cap of $7.54 billion and does not pay a dividend. The company’s stock trades at 546.76 times trailing earnings and at 303.03 times forward earnings. The stock has a very high price-to-sales ratio of 97.68, so it is considered overpriced. The stock also has a price-to-book ratio of 7.59. The company’s revenue has been increasing since 2015, jumping from 1.44 million to 18.07 million and then to 55.2 million over the past few years.

Headquartered in Canada and founded in 2014, Canopy Growth is a licensed producer of medical marijuana. Its product portfolio includes items like dried flowers, oils and concentrates, softgel capsules, and hemp. Canopy Growth has a market cap of $10.8 billion and does not pay a dividend. The stock’s high price-to-sales ratio of 134.27 puts it well into the overpriced category. The stock also has a price-to-book ratio of 11.71. With its revenue increasing each fiscal year since 2014, Canopy Growth boasts a 3-year revenue growth rate of 266.47% and an even higher 5-year revenue growth rate of 724.53%. Most of the company’s revenue comes from its sales of medical marijuana under two of its brands, Tweed and Bedrocan.

Constellation Brands is a large alcoholic beverage supplier in the United States that produces beer, wine, and spirits. The company bought a large stake in the previous mentioned Canopy Growth. It is currently working on creating its own cannabis-infused non-alcoholic beverage. Constellation Brands has a market cap of $40.8 billion and pays a dividend yield of 1.39%. The stock trades at 22.04 times trailing earnings and at 21.83 times forward earnings. The stock has a high price-to-sales ratio of 5.5 and a price-to-book ratio of 3.82. With its revenue increasing each fiscal year since 2014, Constellation Brands enjoys a 3-year revenue growth rate of 7.96% and an even higher 5-year revenue growth rate 22.09%. Most of the company’s revenue come from its sales within the United States.

You might also consider Cronos Group, another cannabis company involved in the production and distribution of marijuana in countries such as Canada, Germany, and Australia. It sells dried cannabis and cannabis oils under its brand Peace Naturals. The company is headquartered in Toronto, Canada and was founded in 2012. Cronos Group has a market cap of $2.36 billion and does not pay a dividend yield. The stock trades at 917.86 times trailing earnings and at 129.87 times forward earnings. The stock has a price-to-book ratio of 10.68 and a very high price-to-sales ratio of 349.40. The company has seen increasing revenue values each fiscal year since 2015.

Based in the United Kingdom and founded in 1998, GW Pharmaceuticals is a biopharmaceutical company that researches and develops cannabinoid products for use in different disease areas. One of its products, Epidiolex, is derived from an active marijuana ingredient and is used to treat various rare childhood-onset epilepsy disorders. The company primarily does business in Canada, Europe, the United States, and Asia. GW Pharmaceuticals has a market cap of $4.78 billion and does not pay a dividend yield. The stock has a price-to-book ratio of 9.36 and a very high price-to-sales ratio of 245.76. The company’s revenue has been falling each fiscal year since 2014, giving the company a negative 3-year revenue growth rate of -35.03% and a negative 5-year revenue growth rate of -24.29%.

Another option is Scotts Miracle-Gro, the largest provider of gardening and lawn care products in the United States. Headquartered in Ohio and founded in 1868, the company sells most of its products to retailers such as Home Depot, Lowe’s, and Walmart. Over recent years, the company has taken steps towards growing its hydroponics business, one of these actions being its acquisition of hydroponic equipment maker, Sunlight Supply Inc. Medical cannabis can be grown through hydroponics, so this transition has given Scotts Miracle-Gro its association with cannabis. Scotts Miracle-Gro has a market cap of $4.34 billion and has a yield of 2.82%. The stock trades at 17.96 times trailing earnings and at 17.48 times forward earnings. The stock has a price-to-book ratio of 8.34 and a normal price-to-sales ratio of 1.73. The company has a 3-year revenue growth rate of 0.82% and a negative 5-year revenue growth rate of -0.94%.

Tilray is a pharmaceutical company that researches, develops and sells medical cannabis. The company was founded in 2018 and is based in Canada. The company’s product portfolio includes dried cannabis as well as cannabis extract in the form of purified oil drops and capsules. Most of the Tilray’s revenue comes from its sales within Canada, but the company also sells its products in Argentina, Australia, Chile, Germany, South Africa, and many other countries. Tilray has a market cap of $11.99 billion and does not pay a dividend. The stock trades at 2500 times forward earnings. Its stock has a price-to-book ratio of 414.61 and a very high price-to-sales ratio of 374.42.

The cannabis industry should continue to grow as more and more states continue to legalize, and as more and more of the large blue-chip marijuana companies jump in.

Stocks Going Ex Dividend the Second Week of October

Here is our latest update on the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets, and can work in flat or choppy markets, but you need to avoid the technique during bear markets.

In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can’t sell the stock until after the ex date. The actual dividend may not be paid for another few weeks.

WallStreetNewsNetwork.com has compiled a downloadable and sortable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million, and yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, and the dividend amount.

Gas Natural Inc. EGAS 10/11/2016 0.08
Harvest Capital Credit Corporation HCAP 10/11/2016 0.11
Humana Inc. HUM 10/11/2016 0.29
Invacare Corp IVC 10/11/2016 0.01
Kadant Inc. KAI 10/11/2016 0.19
Abbott Laboratories ABT 10/12/2016 0.26
AbbVie Inc. ABBV 10/12/2016 0.57
Ampco Pittsburgh Corp AP 10/12/2016 0.09

The additional ex-dividend stocks can be found here at wstnn.com. (If you have been to the website before, and the latest link doesn’t show up, you may have to empty your cache.) If you like dividend stocks, you should check out some of the other high yield stock lists at WallStreetNewsNetwork.com or WSNN.com. Most of the lists are free.

Dividend definitions:

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Monthly Dividend Stock List

Record date: the day when you must be on the company’s books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

Book now available: Buying Dividends Revised and Expanded

Book now available: Stock Market Trivia Makes a Great Gift!

Don’t forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written.